BLFS
Price
$25.45
Change
+$0.41 (+1.64%)
Updated
Sep 4, 01:54 PM (EDT)
Capitalization
1.2B
63 days until earnings call
PLSE
Price
$15.26
Change
+$0.27 (+1.80%)
Updated
Sep 4, 02:30 PM (EDT)
Capitalization
1.01B
74 days until earnings call
Interact to see
Advertisement

BLFS vs PLSE

Header iconBLFS vs PLSE Comparison
Open Charts BLFS vs PLSEBanner chart's image
BioLife Solutions
Price$25.45
Change+$0.41 (+1.64%)
Volume$1.4K
Capitalization1.2B
Pulse Biosciences
Price$15.26
Change+$0.27 (+1.80%)
Volume$100
Capitalization1.01B
BLFS vs PLSE Comparison Chart in %
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLFS vs. PLSE commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a StrongBuy and PLSE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (BLFS: $25.04 vs. PLSE: $14.99)
Brand notoriety: BLFS and PLSE are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BLFS: 80% vs. PLSE: 77%
Market capitalization -- BLFS: $1.2B vs. PLSE: $1.01B
BLFS [@Pharmaceuticals: Other] is valued at $1.2B. PLSE’s [@Pharmaceuticals: Other] market capitalization is $1.01B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $158.15B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whilePLSE’s FA Score has 0 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • PLSE’s FA Score: 0 green, 5 red.
According to our system of comparison, BLFS is a better buy in the long-term than PLSE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 5 TA indicator(s) are bullish while PLSE’s TA Score has 3 bullish TA indicator(s).

  • BLFS’s TA Score: 5 bullish, 5 bearish.
  • PLSE’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, BLFS is a better buy in the short-term than PLSE.

Price Growth

BLFS (@Pharmaceuticals: Other) experienced а -1.53% price change this week, while PLSE (@Pharmaceuticals: Other) price change was -5.43% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.04%. For the same industry, the average monthly price growth was +6.43%, and the average quarterly price growth was +33.54%.

Reported Earning Dates

BLFS is expected to report earnings on Nov 06, 2025.

PLSE is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.04% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLFS($1.2B) has a higher market cap than PLSE($1.01B). BLFS YTD gains are higher at: -3.544 vs. PLSE (-13.900). BLFS has higher annual earnings (EBITDA): 17.4M vs. PLSE (-71.1M). PLSE has more cash in the bank: 106M vs. BLFS (81.8M). PLSE has less debt than BLFS: PLSE (8.25M) vs BLFS (23.8M). BLFS has higher revenues than PLSE: BLFS (93.5M) vs PLSE (0).
BLFSPLSEBLFS / PLSE
Capitalization1.2B1.01B119%
EBITDA17.4M-71.1M-24%
Gain YTD-3.544-13.90025%
P/E RatioN/AN/A-
Revenue93.5M0-
Total Cash81.8M106M77%
Total Debt23.8M8.25M289%
FUNDAMENTALS RATINGS
BLFS vs PLSE: Fundamental Ratings
BLFS
PLSE
OUTLOOK RATING
1..100
877
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
64
Fair valued
PROFIT vs RISK RATING
1..100
9191
SMR RATING
1..100
9299
PRICE GROWTH RATING
1..100
4663
P/E GROWTH RATING
1..100
13100
SEASONALITY SCORE
1..100
1850

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PLSE's Valuation (64) in the Medical Specialties industry is somewhat better than the same rating for BLFS (99). This means that PLSE’s stock grew somewhat faster than BLFS’s over the last 12 months.

PLSE's Profit vs Risk Rating (91) in the Medical Specialties industry is in the same range as BLFS (91). This means that PLSE’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's SMR Rating (92) in the Medical Specialties industry is in the same range as PLSE (99). This means that BLFS’s stock grew similarly to PLSE’s over the last 12 months.

BLFS's Price Growth Rating (46) in the Medical Specialties industry is in the same range as PLSE (63). This means that BLFS’s stock grew similarly to PLSE’s over the last 12 months.

BLFS's P/E Growth Rating (13) in the Medical Specialties industry is significantly better than the same rating for PLSE (100). This means that BLFS’s stock grew significantly faster than PLSE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFSPLSE
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 14 days ago
85%
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FMSRX17.020.10
+0.59%
Frontier MFG Global Sustainable Svc
TSRMX16.330.06
+0.37%
Touchstone Sands Cptl Emerg Mkts Gr R6
PXWEX35.320.09
+0.26%
Impax Ellevate Global Women's Ldr Inv
NBPIX49.95-0.10
-0.20%
Neuberger Berman Large Cap Value Instl
VNVCX21.69-0.05
-0.23%
Natixis Vaughan Nelson Mid Cap C

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with RGEN. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
-1.18%
RGEN - BLFS
59%
Loosely correlated
-3.74%
A - BLFS
51%
Loosely correlated
+0.01%
RVTY - BLFS
50%
Loosely correlated
-5.13%
TWST - BLFS
49%
Loosely correlated
-0.91%
AZTA - BLFS
49%
Loosely correlated
-2.62%
More

PLSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLSE has been loosely correlated with CERS. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PLSE jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLSE
1D Price
Change %
PLSE100%
-0.79%
CERS - PLSE
37%
Loosely correlated
+3.15%
BLFS - PLSE
32%
Poorly correlated
-1.18%
VAPO - PLSE
31%
Poorly correlated
N/A
CLPT - PLSE
31%
Poorly correlated
-1.73%
TMCI - PLSE
31%
Poorly correlated
+1.12%
More